combination therapies [topp]    
radiofrequency ablation [topp]    
Transarterial Chemoembolization [topp]    
Recurrent Hepatocellular Carcinoma [neop]    
Hepatectomies [topp]    
Compare [acty]    
Single [popg]    
treatment [ftcn]    
Assess [acty]    
Efficacy [qlco]    
Safeties [hcpp]    
radiofrequency ablation [topp]    
Combination [qlco]    
Transarterial Chemoembolization [topp]    
Recurrent Hepatocellular Carcinoma [neop]    
Hepatectomies [topp]    
To [qlco]    
Compare [acty]    
Outcome [ftcn]    
Single [popg]    
modalities [idcn]    
studies [mnob]    
patient [podg]    
Recurrence [tmco]    
HCC [gngm]    
Hepatectomies [topp]    
Exclude [idcn]    
Repeat [ftcn]    
Hepatectomies [topp]    
patient [podg]    
Male [fndg]    
Female [fndg]    
Mean [qnco]    
Age-Years [tmco]    
55 [inpr]    
Ranges [qnco]    
year [tmco]    
treatment [ftcn]    
modalities [idcn]    
patient [podg]    
Divide [ftcn]    
Three [qnco]    
Group [idcn]    
radiofrequency ablation [topp]    
used [fndg]    
Sole [blor]    
First-Line Treatment [topp]    
patient [podg]    
radiofrequency ablation [topp]    
Group [idcn]    
Transarterial Chemoembolization [topp]    
used [fndg]    
Sole [blor]    
First-Line Treatment [topp]    
patient [podg]    
Transarterial Chemoembolization [topp]    
Group [idcn]    
radiofrequency ablation [topp]    
followed [tmco]    
Transarterial Chemoembolization [topp]    
Perform [ftcn]    
31 [inpr]    
patient [podg]    
Combination [qlco]    
Group [idcn]    
Significance [qnco]    
*Difference [qnco]    
Clinical [qlco]    
Material [sbst]    
Three [qnco]    
Group [idcn]    
Index [inpr]    
include [ftcn]    
successful treatment [qlco]    
Rate [acty]    
intrahepatic [spco]    
Recurrence [phpr]    
Rate [acty]    
Survival [acty]    
Obtain [ftcn]    
Analysis [lbpr]    
Comparison [acty]    
successful treatment [qlco]    
Rate [acty]    
Combination [qlco]    
Group [idcn]    
High [qlco]    
Transarterial Chemoembolization [topp]    
Group [idcn]    
68 [inpr]    
intrahepatic [spco]    
Recurrence [phpr]    
Rate [acty]    
Combination [qlco]    
Group [idcn]    
Lower [spco]    
Transarterial Chemoembolization [topp]    
Group [idcn]    
radiofrequency ablation [topp]    
Group [idcn]    
Overall [inpr]    
<3 [qnco]    
>5 [qnco]    
year [tmco]    
Survival Rate [qnco]    
radiofrequency ablation [topp]    
Group [idcn]    
65 [inpr]    
Transarterial Chemoembolization [topp]    
Group [idcn]    
Combination [qlco]    
Group [idcn]    
Significance [qnco]    
*Difference [qnco]    
Survival [acty]    
Combination [qlco]    
Group [idcn]    
Transarterial Chemoembolization [topp]    
Group [idcn]    
radiofrequency ablation [topp]    
Combination [qlco]    
Transarterial Chemoembolization [topp]    
More [ftcn]    
Effect [qlco]    
TREAT [topp]    
Recurrent Hepatocellular Carcinoma [neop]    
Hepatectomies [topp]    
Compare [acty]    
Single [popg]    
radiofrequency ablation [topp]    
Transarterial Chemoembolization [topp]    
treatment [ftcn]    
This [euka]    
combination therapies [topp]    
choice [inbe]    
treatment [ftcn]    
Recurrent Hepatocellular Carcinoma [neop]    
